36 related articles for article (PubMed ID: 1960560)
1. Radiotherapy for Advanced Hodgkin Lymphoma with Initial Bulk: A Combined Analysis of Two Randomized Trials.
Hughes RT; Razavian NB; Shenker RF; Kelsey CR; Smith S; D'Agostino RB; Winkfield KM
Adv Radiat Oncol; 2024 May; 9(5):101450. PubMed ID: 38550369
[TBL] [Abstract][Full Text] [Related]
2. Low-dose palliative radiotherapy for malignant peripheral T-cell lymphoma masked by cellulitis and osteomyelitis: a case report.
Alayed Y
BJR Case Rep; 2024 Jan; 10(1):uaad010. PubMed ID: 38352262
[TBL] [Abstract][Full Text] [Related]
3. Role of Radiation Therapy in Mortality among Adolescents and Young Adults with Lymphoma: Differences According to Cause of Death.
Yin X; You L; Hu X
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291852
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy for patients with stage IV classical Hodgkin lymphoma: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wang S; Jia M; Han J; Zhang R; Huang K; Li P; Li Q; Qiao Y; Song Q; Fu Z
Cancer Biol Ther; 2020 Sep; 21(9):832-840. PubMed ID: 32835569
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era.
Lapuz C; Enjeti AK; O'Brien PC; Capp AL; Holliday EG; Gupta SA
Blood Lymphat Cancer; 2018; 8():13-20. PubMed ID: 31360090
[TBL] [Abstract][Full Text] [Related]
6. Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).
Gordon LI; Hong F; Fisher RI; Bartlett NL; Connors JM; Gascoyne RD; Wagner H; Stiff PJ; Cheson BD; Gospodarowicz M; Advani R; Kahl BS; Friedberg JW; Blum KA; Habermann TM; Tuscano JM; Hoppe RT; Horning SJ
J Clin Oncol; 2013 Feb; 31(6):684-91. PubMed ID: 23182987
[TBL] [Abstract][Full Text] [Related]
7. Does radiotherapy still have a place in Hodgkin lymphoma?
Yahalom J
Curr Hematol Malig Rep; 2009 Jul; 4(3):117-24. PubMed ID: 20425424
[TBL] [Abstract][Full Text] [Related]
8. Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease.
Yahalom J
Curr Oncol Rep; 2002 Sep; 4(5):415-23. PubMed ID: 12162917
[TBL] [Abstract][Full Text] [Related]
9. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Canellos GP
Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
[TBL] [Abstract][Full Text] [Related]
10. Treatment of advanced Hodgkin's disease.
Straus DJ
Hematol Oncol Clin North Am; 1989 Jun; 3(2):287-302. PubMed ID: 2473061
[TBL] [Abstract][Full Text] [Related]
11. Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations.
Yahalom J; Ryu J; Straus DJ; Gaynor JJ; Myers J; Caravelli J; Clarkson BD; Fuks Z
J Clin Oncol; 1991 Dec; 9(12):2193-201. PubMed ID: 1960560
[TBL] [Abstract][Full Text] [Related]
12. Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
Salvagno L; SorarĂ¹ M; Sotti G; Aversa S; Chiarion Sileni V; Mazzarotto R; Scarzello G; Bianco A; Pappagallo GL; Fiorentino MV
Ann Oncol; 1995 Feb; 6(2):173-9. PubMed ID: 7540419
[TBL] [Abstract][Full Text] [Related]
13. Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
Viviani S; Bonadonna G; Santoro A; Bonfante V; Zanini M; Devizzi L; Soncini F; Valagussa P
J Clin Oncol; 1996 May; 14(5):1421-30. PubMed ID: 8622055
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
Connors JM; Klimo P; Adams G; Burns BF; Cooper I; Meyer RM; O'Reilly SE; Pater J; Quirt I; Sadura A; Shustik C; Skillings J; Sutcliffe S; Verma S; Yoshida S; Zee B
J Clin Oncol; 1997 Apr; 15(4):1638-45. PubMed ID: 9193364
[TBL] [Abstract][Full Text] [Related]
15. A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.
Somers R; Carde P; Henry-Amar M; Tarayre M; Thomas J; Hagenbeek A; Monconduit M; de Pauw BE; Breed WP; Verdonck L
J Clin Oncol; 1994 Feb; 12(2):279-87. PubMed ID: 7509381
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]